AAMC offering clinicians COVID-19 guidance from academic medical centers

Healthcare providers have a fresh online resource to consult for emerging best practices on the treatment and management of COVID-19.

It’s the COVID-19 Clinical Guidance Repository, launched and run by the Association of American Medical Colleges.

With the goal of identifying, summarizing and highlighting “areas of alignment in clinical practice during the pandemic,” repository organizers are using the website to compile and present COVID-specific content contributed by academic medical centers across the U.S.

The repository so far has downloadable COVID-19 guidance for infection control, emergency medicine, inpatient care, ambulatory services, serious illness communication, mental health and care for special patient populations such as children.

In introducing the resource, AAMC notes the repository is intended for clinicians, not the general public. The idea is to offer expert information on COVID-19 that supplements clinicians’ own “independent, professional judgment and evaluation of their institution’s unique circumstances.”

Click here to check it out.  

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.